Associate Member, Department of Malignant Hematology
Moffitt Cancer Center
Tampa, Florida
Kendra Sweet, MD, MS, is currently an associate member in the Malignant Hematology Faculty, at Moffitt Cancer Center in Tampa, FL. She also serves as the Director of Clinical Research for the Department of Malignant Hematology. She completed her medical education at Virginia Commonwealth University in Richmond, VA. Her internal medicine residency was completed at University of Arizona in Tucson, AZ, and her hematology and medical oncology fellowship training was done at Moffitt Cancer Center/The University of South Florida. She was awarded a 3-year career development award from the Leukemia and Lymphoma Society in order to support her research efforts for the first 3 years on faculty. She is board certified in medical oncology, hematology and internal medicine.
Dr Sweet is a clinical investigator focusing on AML and CML. She has opened 2 multi-center Phase II clinical trials for which she is the national PI. These 2 trials build on her previous work with ruxolitinib plus TKIs for treatment of chronic myeloid leukemia (CML). One trial is being run through the Southwest Oncology Group Leukemia Committee and the second in the J Khoury Cure CML Consortium. Dr. Sweet also has three investigator initiated trials open in AML. In addition to this, she has been the PI in a number of sponsored clinical trials in AML and BPDCN, and much of her work has led to abstract submissions and presentations at ASH, ASCO and the European School of Hematology Annual Meetings.
Disclosure information not submitted.
Thursday, May 12, 2022
3:20 PM – 4:20 PM
Thursday, May 12, 2022
3:45 PM – 4:05 PM
Thursday, May 12, 2022
4:05 PM – 4:20 PM
Thursday, July 21, 2022
2:20 PM – 3:20 PM
Thursday, July 21, 2022
2:45 PM – 3:05 PM
Thursday, July 21, 2022
3:05 PM – 3:20 PM